Newron Pharmaceuticals S.p.A. NWPHF
Set alert
20.00 USD 0.00 0.00%
At close · Oct 29
9.36 Day range 9.36
9.36 52-week range 20.00
- YTD
- +113.68%
- 1 year
- +113.68%
- Open
- 9.36
- Prev close
- 20.00
- Mkt cap
- 408.95M
- Vol
- 986
- Avg vol
- 0
- EPS
- -0.74
- P/E
- 0.00
More statistics
- Low
- 9.36
- High
- 9.36
News
- Newron Pharmaceuticals S.p.A. (NWPHF) Discusses FDA Clinical Hold and Safety Concerns in ENIGMA-TRS Program for Treatment-Resistant Schizophrenia Transcript
- Newron Pharmaceuticals to Participate in June Investor Conferences
- Newron Pharmaceuticals S.p.A. (NWPHF) Q4 2025 Earnings Call Transcript
- Newron Presents 2025 Financial Results and Provides 2026 Outlook
- Newron to Present at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)
- Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia
- Short Interest in Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Decreases By 23.0%
- EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
- Newron to Host Investor and Partnering Meetings During the J.P. Morgan Healthcare Conference Week
- Newron presents H1 2025 results and provides business update
Your note
Sign in to keep a note on NWPHF — it syncs with the Stock Master app.